About Rocket Pharma
Rocket Pharma is a company based in New York (United States) founded in 2015. Rocket Pharma has completed 1 acquisition, including Renovacor. Rocket Pharma operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter New York, United States
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website rocketpharma.com
- Social LinkedIn X YouTube
- Legal Name Rocket Pharmaceuticals, Inc.
- Latest Funding Round$5M (USD), Post-IPO
Dec 2024
- InvestorsRTW Investments
& 4 more
- Investments & Acquisitions
Apps and channels of Rocket Pharma
its YouTube channel Rocket Pharma has 190 subscribers and 30 videos.
Videos from Rocket Pharma
The most watched videos on Rocket Pharma's YouTube channel, Rocket Pharma (190 subscribers). Click a video to play it here.
More on Rocket Pharma.
Funding Insights of Rocket Pharma
- Total Rounds 6
- Last Round Post-IPO — $5M
- First Round $16.43M
(Jan 2016)
- Investors Count 5
All 6 funding rounds of Rocket Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $5M | Post-IPO | – | – | – |
| Aug 2021 | $26.4M | Post-IPO | – | – | – |
| Nov 2020 | $3.7M | Grant | – | – | |
| Apr 2019 | $6.5M | Grant | – | – | |
| May 2017 | $25.14M | Post-IPO | – | – | |
| Jan 2016 | $16.43M | Post-IPO | – | – | – |
5 investors in total: 5 institutional.
Investors in Rocket Pharma
Rocket Pharma has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include RTW Investments, CIRM and Tavistock Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Sciences focused VC firm investing in the US | 2010 | rtwfunds.com | New York, United States | |
Tavistock Group is engaged in global diversified investments. | – | tavistock.com | - | |
Healthcare startups are funded by this corporate-backed venture capital entity. | – | lifesciventure.com | New York, United States | |
- | – | cirm.ca.gov | - | |
Manages diversified investment portfolios across various asset classes. | 1997 | cormorant.com | Boston, United States |
Investor details for Rocket Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rocket Pharma
123 people are tracked at Rocket Pharma (74 in leadership, 1 in board & advisors, 48 in team).
| Name | Role | Group |
|---|---|---|
Kinnari Patel | Chief Operating Officer & EVP, Development | Leadership |
Tavis B. | Associate Director, Regulatory Operations | Leadership |
Michael Korn | Associate Director, QC - AAV | Leadership |
Leslie B. | Associate Director | Health Economics And Outcomes Research | Leadership |
John Militello | VP, Finance & Senior Controller | Leadership |
Gaurav Shah | CEO & President | Leadership |
Gayatri R. Rao | VP, Regulatory Policy and Patient Advocacy | Leadership |
Susan M | Senior Medical Director | Leadership |
Ramji Krishnan | VP, Manufacturing and Manufacturing Sciences | Leadership |
Jeff Pawar | Vice President Of Technical Operations | Leadership |
Sean B. Cuttler | Vp, Head Of Information Technology | Leadership |
Akshaya Patel | Head Of Global Field Medical Affairs | Leadership |
Jonathan Schwartz | Chief Medical Officer & SVP, Clinical Development | Leadership |
Thomas Faria | Vice President, Head Of Global Medical Affairs | Leadership |
Chantal Petit | Vp, Chief Of Staff Supporting The President/head R&d/coo At Rocket Pharmaceuticals | Leadership |
Mayur Kasetty | Global Program Head, AAV Gene Therapy | Leadership |
Raj Prabhakar | Chief Business Officer and SVP | Leadership |
Jen-Fue Maa | Sr Director Biostatistics | Leadership |
Chester Bittencourt Sacramento | Director, Cell Line & Analytical Research - Nonclinical R&d | Leadership |
Justin Percival | Senior Director, Research | Leadership |
103 more people are available in the full profile.
Complete people profiles for Rocket Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Rocket Pharma
Rocket Pharma is a publicly listed company on the NASDAQ with ticker symbol RCKT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Jan 2018
- Listed onFRA: 9IP1
- Listed entityRocket Pharmaceuticals, Inc.
- Exchange sectorHealth technology
Investments & Acquisitions by Rocket Pharma
Rocket Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Renovacor.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
BAG3-related gene therapies for cardiovascular and CNS disorders are developed. | renovacor.com | Philadelphia, United States | 2013 | Sep 2022 | $53M |
Complete acquisition details for Rocket Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Rocket Pharma
5 dated milestones of Rocket Pharma across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Rocket Pharma is founded.
- Funding First funding round of $16.4M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Renovacor.
- Funding Latest funding round, Post-IPO, of $5.0M.
Competitors of Rocket Pharma
Rocket Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | – | Therapeutics for genetic diseases are developed through targeted interventions. | |
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. | |
| atai.life | 2018 | Munich, Germany | $386.67M | – | A biopharmaceutical company accelerating innovative mental health treatments. | |
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| rhythmtx.com | 2010 | Boston, United States | $84M | 115 | Developer of peptide therapeutics for the treatment of rare genetic deficiencies | |
| horizontherapeutics.com | 2008 | Dublin, Ireland | $61.78M | – | Developer of drugs for treating rare and autoimmune diseases | |
| ultragenyx.com | 2010 | Novato, United States | $135.1M | 837 | Therapeutics for rare and ultra-rare metabolic diseases are developed. |
Detailed competitors of Rocket Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rocket Pharma
The website of Rocket Pharma (rocketpharma.com) receives about 14.7K visits a month and ranks #2,007,864 among all websites worldwide, #2,733 in Biotechnology and Pharmaceuticals.
- Monthly visits14.7K
▲ 26.2% vs previous month
- Unique visitors5.7K
per month
- Global rank#2,007,864
among all websites
- Category rank#2,733
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit1.8
- Average visit30 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Rocket Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| askbio.com | 100% | 14.3K | #2,158,975 | View details | |
insights.bio | insights.bio | 95% | – | #986,365 | – |
| geneonline.com | 92% | 55.1K | #771,598 | View details | |
| drugdiscoverynews.com | 92% | – | #639,360 | View details | |
mmm-online.com | mmm-online.com | 92% | – | #392,799 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Rocket Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Rocket Pharma
Complete news archive for Rocket Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Rocket Pharma
10 companies that operate in the same segment as Rocket Pharma (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rocket Pharma
Rocket Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Rocket Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.
Rocket Pharma was founded in 2015 and is headquartered in New York, United States. Operations are centered in the biotechnology sector, where adeno-associated viral and lentiviral gene therapies are developed to address rare diseases. Specific therapies include RP-L102 for Fanconi anemia, RP-L201 for leukocyte adhesion deficiency, RP-L301 for pyruvate kinase deficiency, RP-L501 for Danon disease, and RP-A601 for PKP2-ACM, among others.
Rocket Pharma's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Yes, Rocket Pharma is publicly traded on NASDAQ under the ticker symbol RCKT.
Rocket Pharma has made 1 acquisition, including Renovacor.
Rocket Pharma has 5 investors. Key investors include RTW Investments, CIRM, Tavistock Group, LifeSci Venture Partners, and Cormorant.
Rocket Pharma operates through Rocket Pharmaceuticals, Inc..